For the year ending 2025-12-31, CAMP made $3,498K in revenue. -$80,403K in net income. Net profit margin of -2298.54%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Research and collaboration revenue | 3,498 | 652 | ||
| Research and development | 38,202 | 38,817 | ||
| General and administrative | 17,357 | 14,923 | ||
| Impairment of right-of-use asset | 494 | - | ||
| Total operating expenses | 56,053 | 53,740 | ||
| Loss from operations | -52,555 | -53,088 | ||
| Interest income | 2,174 | 1,330 | ||
| Change in fair value of derivative tranche liability | -29,830 | - | ||
| Other expense | 192 | 33 | ||
| Total other (expense) income, net | -27,848 | 1,297 | ||
| Net loss | -80,403 | -51,791 | ||
| Other comprehensive income (loss) | 0 | - | ||
| Total comprehensive loss | -80,403 | -51,791 | ||
| Basic EPS | -2.65 | -11.04 | ||
| Diluted EPS | -2.65 | -11.04 | ||
| Basic Average Shares | 30,380,567 | 4,690,094 | ||
| Diluted Average Shares | 30,380,567 | 4,690,094 | ||
Camp4 Therapeutics Corp (CAMP)
Camp4 Therapeutics Corp (CAMP)